The ‘gold standard’ for determining if a new drug is safe and effective to be used to treat disease. Clinical trials must be successfully completed before a drug can be licensed for use in a general patient population.
The MND Association’s vision is a world free from MND. Realising this vision means investing more in research, further developing partnerships with the research community, funding bodies and industry, while ensuring that advances in understanding and treating MND are communicated as quickly and effectively as possible. Our Research Development team, composed of 11 members, work hard to achieve this. Principally, the Research Information team within this are involved in communication activities including this MND Research blog.